0001209191-19-037200.txt : 20190614 0001209191-19-037200.hdr.sgml : 20190614 20190614172039 ACCESSION NUMBER: 0001209191-19-037200 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190412 FILED AS OF DATE: 20190614 DATE AS OF CHANGE: 20190614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Galante Joseph C CENTRAL INDEX KEY: 0001632384 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33637 FILM NUMBER: 19899794 MAIL ADDRESS: STREET 1: 111 TENTH AVENUE STREET 2: SUITE 200 CITY: NASHVILLE STATE: TN ZIP: 37203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001087294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE, STATE: TN ZIP: 37203 BUSINESS PHONE: 615-255-0068 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-04-12 0 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001632384 Galante Joseph C 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203 1 0 0 0 Common Stock 2019-04-12 4 P 0 99 6.32 A 9975 D Common Stock 2019-04-17 4 P 0 81 6.21 A 10056 D Common Stock 2019-04-24 4 P 0 32 6.04 A 10088 D Common Stock 2019-04-25 4 P 0 24 6.17 A 10112 D Common Stock 2019-04-26 4 P 0 14 6.32 A 10126 D Common Stock 2019-04-30 4 P 0 27 6.37 A 10153 D Common Stock 2019-05-02 4 P 0 73 5.61 A 10226 D Common Stock 2019-05-06 4 P 0 42 6.29 A 10268 D Common Stock 2019-05-07 4 P 0 23 6.07 A 10291 D Common Stock 2019-05-08 4 P 0 58 6.35 A 10349 D Common Stock 2019-05-10 4 P 0 57 6.01 A 10406 D Common Stock 2019-05-14 4 P 0 36 5.62 A 10442 D Common Stock 2019-05-17 4 P 0 106 6.25 A 10548 D Common Stock 2019-05-20 4 P 0 60 6.89 A 10608 D Common Stock 2019-05-21 4 P 0 60 6.71 A 10668 D Common Stock 2019-05-22 4 P 0 60 6.58 A 10728 D Common Stock 2019-05-23 4 P 0 60 6.53 A 10788 D Common Stock 2019-05-24 4 P 0 60 6.67 A 10848 D Common Stock 2019-05-28 4 P 0 60 6.65 A 10908 D Common Stock 2019-05-29 4 P 0 60 6.53 A 10968 D Common Stock 2019-05-30 4 P 0 60 6.58 A 11028 D Common Stock 2019-05-31 4 P 0 60 6.57 A 11088 D Common Stock 2019-06-03 4 P 0 60 6.49 A 11148 D Common Stock 2019-06-04 4 P 0 60 6.60 A 11208 D Common Stock 2019-06-05 4 P 0 50 6.67 A 11258 D Common Stock 2019-06-06 4 P 0 60 6.38 A 11318 D Common Stock 2019-06-07 4 P 0 60 6.07 A 11378 D Common Stock 2019-06-10 4 P 0 60 6.09 A 11438 D Common Stock 2019-06-11 4 P 0 60 6.32 A 11498 D Common Stock 2019-06-12 4 P 0 60 6.29 A 11558 D The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Joseph C. Galante by /s/ Michael Bonner as attorney-in-fact 2019-06-14